Latest News

02/13/13 For kidney cancer, this cure’s worse than the disease

By Marilynn Marchione, Associated Press In a stunning example of when treatment might be worse than the disease, a large review of Medicare records finds that older people with small kidney tumors were much less...

Read

02/11/13 Avastin May Help Boost Survival With Aggressive Cervical Cancer: Study

FRIDAY, Feb. 8 (HealthDay News) -- The cancer drug Avastin may extend the lives of patients with aggressive cervical cancer, a new study finds. The findings might change the way these patients are treated and...

Read

02/11/13 On-the-Job Stress Won’t Raise Your Risk for Cancer, Study Finds

THURSDAY, Feb. 7 (HealthDay News) -- The hassles and deadlines at work may leave you frazzled, but they won't raise your risk for cancer, new research suggests. Despite earlier studies suggesting an association between work...

Read

02/5/13 Patient Involvement Lowers Health Costs, Study Says

TUESDAY, Feb. 5 (HealthDay News) -- Patients who take an active role in their health care have lower medical costs, according to a new study. Researchers analyzed data from about 33,000 patients in Minnesota and...

Read

02/4/13 5 Ways to Make a Difference on World Cancer Day

Katie Couric 02/04/2013 10:05 am It's World Cancer Day -- a moment in which we reach across borders and boundaries and unite in our shared quest to end a disease that claims the lives of...

Read

01/28/13 For Early Cancer, Lumpectomy Beats Mastectomy for Survival: Study

MONDAY, Jan. 28 (HealthDay News) -- Breast-conserving surgery for early stage breast cancers may result in better survival than mastectomy, according to a new study. For those with early stage breast cancer, "lumpectomy is just...

Read

01/23/13 Women have caught up to men on lung cancer risk

By MARILYNN MARCHIONE, Associated Press Jan. 23, 2013 2:10PM PST Smoke like a man, die like a man. U.S. women who smoke today have a much greater risk of dying from lung cancer than they...

Read

01/22/13 Celgene’s Abraxane increases survival in pancreatic cancer

By Bill Berkrot, Reuters Jan. 22, 2013 3:01PM PST Celgene Corp said its Abraxane drug helped patients with advanced pancreatic cancer live an average of two months longer than chemotherapy and significantly increased the percentage...

Read

01/18/13 Chemo Pills Effective, But Patients May Skip Doses

THURSDAY, Jan. 17 (HealthDay News) -- Although chemotherapy pills are able to target certain cancers better than traditional intravenous drugs, some patients have trouble taking them, according to new research. A study from researchers at...

Read

01/18/13 U.S. Cancer Death Rates Have Dropped 20 Percent Since 1991

THURSDAY, Jan. 17 (HealthDay News) -- The overall death rate for cancer in the United States has dropped by at least one-fifth over the past two decades, according to new statistics from the American Cancer...

Read

01/16/13 U.S. Minorities Less Likely to Get Colon Cancer Screening: Study

TUESDAY, Jan. 15 (HealthDay News) -- Minority patients in the United States are less likely than whites to be screened for colorectal cancer, a new study finds. Researchers analyzed national data from between 2000 and...

Read

01/13/13 Radiation for Childhood Cancers Increases Breast Cancer Risk

By Lillie Shockney, R.N., M.A.S. Jan 13, 2013 It's tough enough for a child to have to endure a cancer diagnosis and its treatment, but it has become increasingly apparent that radiation during childhood can...

Read

01/9/13 Common Heart Drug Might Improve Lung Cancer Survival

WEDNESDAY, Jan. 9 (HealthDay News) -- New research suggests that beta blockers, medications that are used to control blood pressure and heart rhythms, may also help lung cancer patients live longer. The researchers found that...

Read

01/9/13 Pap Test Could Spot Some Ovarian Cancers, Study Finds

WEDNESDAY, Jan. 9 (HealthDay News) -- With no routine screening test currently available for uterine or ovarian cancer -- the latter of which is extremely lethal -- scientists have found promise in a new method...

Read

01/9/13 Poor people participate in cancer trials less often

By Andrew M. Seaman, Reuters Jan. 09, 2013 1:04PM PST NEW YORK (Reuters Health) - Poor people are less likely to take part in clinical trials for new cancer drugs, which can make it harder...

Read

01/9/13 DNA pioneer James Watson takes aim at “cancer establishments”

By Sharon Begley, Reuters Jan. 09, 2013 3:34AM PST NEW YORK (Reuters) - A day after an exhaustive national report on cancer found the United States is making only slow progress against the disease, one...

Read

01/7/13 Costly Breast Cancer Screenings May Not Help Seniors: Study

MONDAY, Jan. 7 (HealthDay News) -- Medicare spends more than $1 billion each year for breast cancer screenings such as mammography, according to a new study. However, all that expenditure may not help produce better...

Read

01/7/13 Some HPV-Linked Cancers Rising in U.S.: Report

MONDAY, Jan. 7 (HealthDay News) -- Although the news on the U.S. cancer front is generally good, experts report a troubling upswing in a few uncommon cancers linked to the sexually transmitted human papillomavirus (HPV)....

Read

12/27/12 Some cancer docs say their income tied to treatments

NEW YORK (Reuters Health) - A survey of cancer doctors finds that some believe they get paid more when they administer their patients' chemotherapy and other drugs, raising concerns about conflict of interest and the...

Read

12/15/12 Major cancer breakthrough by Toronto scientists: Cancer cells go dormant during chemotherapy

A team of Toronto cancer researchers have made a breakthrough they say will change the way cancer is studied and even treated. The team, led by stem cell scientist John Dick of The Princess Margaret...

Read
1 96 97 98 99 100 102